Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

The incidence of consecutive manifestations in Von Hippel-Lindau disease.

van der Horst-Schrivers ANA, Sluiter WJ, Kruizinga RC, van Leeuwaarde RS, Giles R, Olderode-Berends MJW, Links TP.

Fam Cancer. 2019 Jul;18(3):369-376. doi: 10.1007/s10689-019-00131-x.

2.

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis.

de Heer EC, Brouwers AH, Boellaard R, Sluiter WJ, Diercks GFH, Hospers GAP, de Vries EGE, Jalving M.

EJNMMI Res. 2018 Nov 20;8(1):101. doi: 10.1186/s13550-018-0453-x.

3.

Postoperative use of somatostatin analogs and mortality in patients with acromegaly.

Postma MR, Wolters TLC, van den Berg G, van Herwaarden AE, Muller Kobold AC, Sluiter WJ, Wagenmakers MA, van den Bergh ACM, Wolffenbuttel BHR, Hermus ARMM, Netea-Maier RT, van Beek AP.

Eur J Endocrinol. 2019 Jan 1;180(1):1-9. doi: 10.1530/EJE-18-0166.

PMID:
30400068
4.

Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.

Berends AMA, Buitenwerf E, Gruppen EG, Sluiter WJ, Bakker SJL, Connelly MA, Kerstens MN, Dullaart RPF.

Clin Endocrinol (Oxf). 2019 Jan;90(1):79-87. doi: 10.1111/cen.13891. Epub 2018 Nov 20.

PMID:
30372543
5.

Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study.

Gruppen EG, Connelly MA, Sluiter WJ, Bakker SJL, Dullaart RPF.

Clin Chim Acta. 2019 Jan;488:7-12. doi: 10.1016/j.cca.2018.10.029. Epub 2018 Oct 23.

PMID:
30365925
6.

Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.

Dekker BL, van der Horst-Schrivers ANA, Sluiter WJ, Brouwers AH, Lentjes EGWM, Heijboer AC, Muller Kobold AC, Links TP.

Thyroid. 2019 Jan;29(1):71-78. doi: 10.1089/thy.2018.0195. Epub 2018 Dec 18.

PMID:
30351209
7.

Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).

Ormel HL, van der Schoot GGF, Westerink NL, Sluiter WJ, Gietema JA, Walenkamp AME.

Support Care Cancer. 2018 Nov;26(11):3915-3923. doi: 10.1007/s00520-018-4263-5. Epub 2018 May 21.

8.

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review.

Ormel HL, van der Schoot GGF, Sluiter WJ, Jalving M, Gietema JA, Walenkamp AME.

Psychooncology. 2018 Mar;27(3):713-724. doi: 10.1002/pon.4612. Epub 2018 Jan 26.

9.

Life expectancy is unaffected by thyroid function parameters in euthyroid subjects: The PREVEND cohort study.

van Tienhoven-Wind LJN, Gruppen EG, Sluiter WJ, Bakker SJL, Dullaart RPF.

Eur J Intern Med. 2017 Dec;46:e36-e39. doi: 10.1016/j.ejim.2017.10.017. Epub 2017 Nov 6. No abstract available.

PMID:
29122438
10.

Cholesterol delivery to the adrenal glands estimated by adrenal venous sampling: An in vivo model to determine the contribution of circulating lipoproteins to steroidogenesis in humans.

Buitenwerf E, Dullaart RPF, Muller Kobold AC, Links TP, Sluiter WJ, Connelly MA, Kerstens MN.

J Clin Lipidol. 2017 May - Jun;11(3):733-738. doi: 10.1016/j.jacl.2017.03.018. Epub 2017 Apr 5.

PMID:
28461157
11.

The clinical value of regular thyroid function tests during amiodarone treatment.

Benjamens S, Dullaart RPF, Sluiter WJ, Rienstra M, van Gelder IC, Links TP.

Eur J Endocrinol. 2017 Jul;177(1):9-14. doi: 10.1530/EJE-17-0018. Epub 2017 Apr 19.

PMID:
28424174
12.

Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma.

Groen AH, Klein Hesselink MS, Plukker JT, Sluiter WJ, van der Horst-Schrivers AN, Brouwers AH, Lentjes EG, Muller Kobold AC, Links TP.

Clin Endocrinol (Oxf). 2017 Mar;86(3):419-424. doi: 10.1111/cen.13180. Epub 2016 Sep 28.

PMID:
27588675
13.

Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers.

Eijkelenkamp K, Osinga TE, de Jong MM, Sluiter WJ, Dullaart RP, Links TP, Kerstens MN, van der Horst-Schrivers AN.

Fam Cancer. 2017 Jan;16(1):123-130. doi: 10.1007/s10689-016-9923-3.

14.

89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

Oosting SF, van Asselt SJ, Brouwers AH, Bongaerts AH, Steinberg JD, de Jong JR, Lub-de Hooge MN, van der Horst-Schrivers AN, Walenkamp AM, Hoving EW, Sluiter WJ, Zonnenberg BA, de Vries EG, Links TP.

J Nucl Med. 2016 Aug;57(8):1244-50. doi: 10.2967/jnumed.115.167643. Epub 2016 May 12.

15.

Potential value of EUS in pancreatic surveillance of VHL patients.

van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Koopmans KP, Kema IP, Zonnenberg BA, Timmers HJ, de Herder WW, Sluiter WJ, de Vries EG, Links TP.

Eur J Endocrinol. 2016 May;174(5):611-20. doi: 10.1530/EJE-15-1012. Epub 2016 Feb 16.

PMID:
26884551
16.

Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.

Werumeus Buning J, Brummelman P, Koerts J, Dullaart RP, van den Berg G, van der Klauw MM, Sluiter WJ, Tucha O, Wolffenbuttel BH, van Beek AP.

Neuroendocrinology. 2016;103(6):771-8. doi: 10.1159/000442985. Epub 2015 Dec 9.

17.

Bone Marrow Function After (131)I Therapy in Patients With Differentiated Thyroid Carcinoma.

Prinsen HT, Klein Hesselink EN, Brouwers AH, Plukker JT, Sluiter WJ, van der Horst-Schrivers AN, van Imhoff GW, Links TP.

J Clin Endocrinol Metab. 2015 Oct;100(10):3911-7. doi: 10.1210/jc.2015-2124. Epub 2015 Aug 11.

PMID:
26262436
18.

Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.

van der Horst-Schrivers AN, Sluiter WJ, Muller Kobold AC, Wolffenbuttel BH, Plukker JT, Bisschop PH, de Klerk JM, Al Younis I, Lips P, Smit JW, Brouwers AH, Links TP.

PLoS One. 2015 Mar 20;10(3):e0120184. doi: 10.1371/journal.pone.0120184. eCollection 2015.

19.

Brain abnormalities on MRI in non-functioning pituitary adenoma patients treated with or without postoperative radiotherapy.

Sattler MG, Meiners LC, Sluiter WJ, van den Berg G, Langendijk JA, Wolffenbuttel BH, van den Bergh AC, van Beek AP.

Radiother Oncol. 2015 Feb;114(2):239-44. doi: 10.1016/j.radonc.2015.01.003. Epub 2015 Jan 14.

PMID:
25596913
20.

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.

Tamas K, Domanska UM, van Dijk TH, Timmer-Bosscha H, Havenga K, Karrenbeld A, Sluiter WJ, Beukema JC, van Vugt MA, de Vries EG, Hospers GA, Walenkamp AM.

Curr Pharm Des. 2015;21(17):2276-83.

PMID:
25557636
21.

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.

van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.

Gastrointest Endosc. 2015 Jan;81(1):159-167.e2. doi: 10.1016/j.gie.2014.09.037.

PMID:
25527055
22.

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

Oosting SF, Brouwers AH, van Es SC, Nagengast WB, Oude Munnink TH, Lub-de Hooge MN, Hollema H, de Jong JR, de Jong IJ, de Haas S, Scherer SJ, Sluiter WJ, Dierckx RA, Bongaerts AH, Gietema JA, de Vries EG.

J Nucl Med. 2015 Jan;56(1):63-9. doi: 10.2967/jnumed.114.144840. Epub 2014 Dec 4.

23.

Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines.

Verbeek HH, Meijer JA, Zandee WT, Kramp KH, Sluiter WJ, Smit JW, Kievit J, Links TP, Plukker JT.

Ann Surg Oncol. 2015 Apr;22(4):1207-13. doi: 10.1245/s10434-014-4115-6. Epub 2014 Oct 15.

PMID:
25316487
24.

Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.

van Enckevort CC, de Graaf AP, Hollema H, Sluiter WJ, Kleibeuker JH, Koornstra JJ.

Neth J Med. 2014 Apr;72(3):139-45.

25.

Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.

van Asselt SJ, Oosting SF, Brouwers AH, Bongaerts AH, de Jong JR, Lub-de Hooge MN, Oude Munnink TH, Fiebrich HB, Sluiter WJ, Links TP, Walenkamp AM, de Vries EG.

J Nucl Med. 2014 Jul;55(7):1087-92. doi: 10.2967/jnumed.113.129056. Epub 2014 May 1.

26.

Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.

Jalving M, Heijink DM, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, Sluiter WJ, de Vries EG, Kleibeuker JH, de Jong S.

Carcinogenesis. 2014 May;35(5):1092-9. doi: 10.1093/carcin/bgt484. Epub 2013 Dec 30.

PMID:
24379239
27.

Similar adverse pregnancy outcome in native and nonnative dutch women with pregestational type 2 diabetes: a multicentre retrospective study.

Groen B, Links TP, van den Berg PP, Hellinga M, Moerman S, Visser GH, Sluiter WJ, Faas MM, Schreuder MC, Visser W, Geelhoed-Duijvestijn PH, Bianchi R, Bartelink AK, de Valk HW.

ISRN Obstet Gynecol. 2013 Oct 30;2013:361435. doi: 10.1155/2013/361435. eCollection 2013.

28.

Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.

Kruizinga RC, Sluiter WJ, de Vries EG, Zonnenberg BA, Lips CJ, van der Horst-Schrivers AN, Walenkamp AM, Links TP.

Endocr Relat Cancer. 2013 Dec 20;21(1):63-71. doi: 10.1530/ERC-13-0308. Print 2014 Feb.

PMID:
24132471
29.

Incidence, causative mechanisms, and anatomic localization of stroke in pituitary adenoma patients treated with postoperative radiation therapy versus surgery alone.

Sattler MG, Vroomen PC, Sluiter WJ, Schers HJ, van den Berg G, Langendijk JA, Wolffenbuttel BH, van den Bergh AC, van Beek AP.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):53-9. doi: 10.1016/j.ijrobp.2013.05.006.

PMID:
23920387
30.

18-fluorodeoxyglucose positron emission tomography in the early diagnostic workup of differentiated thyroid cancer patients with a negative post-therapeutic iodine scan and detectable thyroglobulin.

van Dijk D, Plukker JT, Phan HT, Muller Kobold AC, van der Horst-Schrivers AN, Jansen L, Sluiter WJ, Brouwers AH, Links TP.

Thyroid. 2013 Aug;23(8):1003-9. doi: 10.1089/thy.2012.0498. Epub 2013 Jul 31.

PMID:
23517405
31.

Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges.

Osinga TE, van den Eijnden MH, Kema IP, Kerstens MN, Dullaart RP, de Jong WH, Sluiter WJ, Links TP, van der Horst-Schrivers AN.

J Clin Endocrinol Metab. 2013 Mar;98(3):1076-83. doi: 10.1210/jc.2012-3418. Epub 2013 Jan 30.

PMID:
23365125
32.

Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus.

de Vries R, Dikkeschei BD, Sluiter WJ, Dallinga-Thie GM, van Tol A, Dullaart RP.

Clin Lab. 2012;58(11-12):1231-9.

PMID:
23289194
33.

Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease.

Frantzen C, Kruizinga RC, van Asselt SJ, Zonnenberg BA, Lenders JW, de Herder WW, Walenkamp AM, Giles RH, Hes FJ, Sluiter WJ, van Pampus MG, Links TP.

Neurology. 2012 Aug 21;79(8):793-6. doi: 10.1212/WNL.0b013e3182661f3c. Epub 2012 Aug 8.

PMID:
22875085
34.

The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.

Sattler MG, van Beek AP, Wolffenbuttel BH, van den Berg G, Sluiter WJ, Langendijk JA, van den Bergh AC.

Radiother Oncol. 2012 Jul;104(1):125-30. doi: 10.1016/j.radonc.2012.04.024. Epub 2012 Jun 8.

35.

Diagnostic yield of small bowel capsule endoscopy depends on the small bowel transit time.

Westerhof J, Koornstra JJ, Hoedemaker RA, Sluiter WJ, Kleibeuker JH, Weersma RK.

World J Gastroenterol. 2012 Apr 7;18(13):1502-7. doi: 10.3748/wjg.v18.i13.1502.

36.

Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.

Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, van den Bergh AC, Wolffenbuttel BH, Hermus AR, van Beek AP.

Eur J Endocrinol. 2012 Apr;166(4):585-92. doi: 10.1530/EJE-11-0853. Epub 2012 Jan 16.

PMID:
22250074
37.

Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study.

Peters TT, Langendijk JA, Plaat BE, Wedman J, Roodenburg JL, van Dijk BA, Sluiter WJ, van der Laan BF, Halmos GB.

Oral Oncol. 2011 Dec;47(12):1159-64. doi: 10.1016/j.oraloncology.2011.08.004. Epub 2011 Aug 31.

PMID:
21885328
38.

Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption.

Kerstens MN, Kobold AC, Volmer M, Koerts J, Sluiter WJ, Dullaart RP.

Clin Chem. 2011 Nov;57(11):1607-11. doi: 10.1373/clinchem.2011.165662. Epub 2011 Aug 24.

39.

Retrospective study on the treatment outcome of surgical closure of oroantral communications.

Visscher SH, van Roon MR, Sluiter WJ, van Minnen B, Bos RR.

J Oral Maxillofac Surg. 2011 Dec;69(12):2956-61. doi: 10.1016/j.joms.2011.02.102. Epub 2011 Jul 14.

PMID:
21752508
40.

P51. Pregnancy stimulates cerebellar hemangioblastoma growth in von Hippel-Lindau disease.

Frantzen C, Kruizinga RC, van Asselt SJ, Zonnenberg BA, Lenders JW, de Herder WW, Walenkamp AM, Giles RH, Hes FJ, Sluiter WJ, Links TP, van Pampus MG.

Pregnancy Hypertens. 2011 Jul-Oct;1(3-4):297. doi: 10.1016/j.preghy.2011.08.112. Epub 2011 Sep 29. No abstract available.

PMID:
26009144
41.

Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.

Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, Sluiter WJ, Dullaart RP.

Eur J Clin Invest. 2011 Aug;41(8):820-7. doi: 10.1111/j.1365-2362.2011.02471.x. Epub 2011 Jan 31.

PMID:
21281278
42.

Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue.

Fiebrich HB, Van Den Berg G, Kema IP, Links TP, Kleibeuker JH, Van Beek AP, Walenkamp AM, Sluiter WJ, De Vries EG.

Aliment Pharmacol Ther. 2010 Dec;32(11-12):1398-404. doi: 10.1111/j.1365-2036.2010.04479.x. Epub 2010 Oct 7.

43.

The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial ¹³¹I therapy.

van Dijk D, Plukker JT, van der Horst-Schrivers AN, Jansen L, Brouwers AH, Muller-Kobold A, Sluiter WJ, Links TP.

Clin Endocrinol (Oxf). 2011 Jan;74(1):104-10. doi: 10.1111/j.1365-2265.2010.03885.x.

PMID:
21039721
44.

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.

Kappelle PJ, Ahnström J, Dikkeschei BD, de Vries R, Sluiter WJ, Wolffenbuttel BH, van Tol A, Nielsen LB, Dahlbäck B, Dullaart RP.

Atherosclerosis. 2010 Nov;213(1):247-50. doi: 10.1016/j.atherosclerosis.2010.07.048. Epub 2010 Aug 10.

PMID:
20828695
45.

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study.

Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, van der Velden J, Hermans RH, van der Putten HW, Drouin P, Runnebaum IB, Sluiter WJ, van der Zee AG.

Lancet Oncol. 2010 Jul;11(7):646-52. doi: 10.1016/S1470-2045(10)70104-2. Epub 2010 May 25.

PMID:
20537946
46.

HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment.

Dullaart RP, van den Berg G, van der Knaap AM, Dijck-Brouwer J, Dallinga-Thie GM, Zelissen PM, Sluiter WJ, van Beek AP.

Eur J Endocrinol. 2010 Feb;162(2):227-34. doi: 10.1530/EJE-09-0742. Epub 2009 Nov 19.

PMID:
19926784
47.

Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

Dullaart RP, Perton F, Kappelle PJ, de Vries R, Sluiter WJ, van Tol A.

Biochim Biophys Acta. 2010 Jan;1801(1):84-8. doi: 10.1016/j.bbalip.2009.09.019. Epub 2009 Oct 1.

PMID:
19800416
48.

Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10).

Lutgers HL, Gerrits EG, Sluiter WJ, Ubink-Veltmaat LJ, Landman GW, Links TP, Gans RO, Smit AJ, Bilo HJ.

PLoS One. 2009 Aug 28;4(8):e6817. doi: 10.1371/journal.pone.0006817.

49.

High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.

Dullaart RP, Perton F, van der Klauw MM, Hillege HL, Sluiter WJ; PREVEND Study Group.

Atherosclerosis. 2010 Feb;208(2):537-42. doi: 10.1016/j.atherosclerosis.2009.07.042. Epub 2009 Jul 30.

PMID:
19698944
50.

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.

J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054. Epub 2009 Jul 21.

PMID:
19622618

Supplemental Content

Loading ...
Support Center